Related references
Note: Only part of the references are listed.Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
Raul Ortiz et al.
CURRENT NEUROPHARMACOLOGY (2021)
The scrambled story between hyaluronan and glioblastoma
Matias Arturo Pibuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Glypican-1 in human glioblastoma: implications in tumorigenesis and chemotherapy
Eduardo Listik et al.
Oncotarget (2020)
The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review
Elmira Mohtashami et al.
CURRENT DRUG METABOLISM (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Proteoglycans as Therapeutic Targets in Brain Cancer
Zoya Yan et al.
FRONTIERS IN ONCOLOGY (2020)
Considering the Experimental Use of Temozolomide in Glioblastoma Research
Verena J. Herbener et al.
BIOMEDICINES (2020)
Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment
Valeria De Pasquale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Proteoglycans remodeling in cancer: Underlying molecular mechanisms
Achilleas D. Theocharis et al.
MATRIX BIOLOGY (2019)
Astrocytes, the rising stars of the glioblastoma microenvironment
Mayra Brandao et al.
GLIA (2019)
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
Marta Cenciarini et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix
Adam Hatoum et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription
Lei Chen et al.
PHYTOTHERAPY RESEARCH (2019)
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
Anne Dirkse et al.
NATURE COMMUNICATIONS (2019)
Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies
Daniel Dubinski et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
Surfen-mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion
Meghan T. Logun et al.
FASEB JOURNAL (2019)
The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer
Adam Pudelko et al.
FEBS JOURNAL (2019)
On the Critical Issues in Temozolomide Research in Glioblastoma: Clinically Relevant Concentrations and MGMT-independent Resistance
Aleksei A. Stepanenko et al.
BIOMEDICINES (2019)
Biomimetic models to examine microenvironmental regulation of glioblastoma stem cells
Pinaki S. Nakod et al.
CANCER LETTERS (2018)
Proteoglycans in brain development and pathogenesis
Nancy B. Schwartz et al.
FEBS LETTERS (2018)
Extracellular matrix: The driving force of mammalian diseases
Renato V. Iozzo et al.
MATRIX BIOLOGY (2018)
Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma
Yangjin Kim et al.
PLOS ONE (2018)
Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo
Alexandra Y. Tsidulko et al.
FRONTIERS IN PHARMACOLOGY (2018)
Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture
Maria Angeles Marques-Torrejon et al.
DISEASE MODELS & MECHANISMS (2018)
Humanized Chondroitinase ABC Sensitizes Glioblastoma Cells to Temozolomide
Alena Cristina Jaime-Ramirez et al.
JOURNAL OF GENE MEDICINE (2017)
Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion
Vy M. Tran et al.
MOLECULAR CANCER RESEARCH (2017)
The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment
Amanda L. Placone et al.
TUMOR BIOLOGY (2016)
DNA repair mechanisms and their clinical impact in glioblastoma
Helene Erasimus et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model
Onyinyechukwu Okolie et al.
NEURO-ONCOLOGY (2016)
Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model
Stine Skov Jensen et al.
PLOS ONE (2016)
Repair mechanisms help glioblastoma resist treatment
Ryan J. Atkins et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Mouse models of glioma
Stanley S. Stylli et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells
Cristiano Farace et al.
PLOS ONE (2015)
Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target
Melanie Jackson et al.
CARCINOGENESIS (2015)
Proteoglycans and their roles in brain cancer
Anna Wade et al.
FEBS JOURNAL (2013)
Chondroitin Sulfate Proteoglycans Potently Inhibit Invasion and Serve as a Central Organizer of the Brain Tumor Microenvironment
Daniel J. Silver et al.
JOURNAL OF NEUROSCIENCE (2013)
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
Tor-Christian Aase Johannessen et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
Caroline Happold et al.
JOURNAL OF NEUROCHEMISTRY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Dagmar Beier et al.
MOLECULAR CANCER (2011)
Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease
Christina Malavaki et al.
CONNECTIVE TISSUE RESEARCH (2008)
Preparation of organotypic hippocampal slice cultures for long-term live imaging
Nadine Gogolla et al.
NATURE PROTOCOLS (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)